Retirement Systems of Alabama Sells 176 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

Retirement Systems of Alabama reduced its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 0.4% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 43,119 shares of the medical device company’s stock after selling 176 shares during the period. Retirement Systems of Alabama’s holdings in Cooper Companies were worth $3,964,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of COO. Mather Group LLC. raised its position in Cooper Companies by 7.4% during the 4th quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock valued at $177,000 after purchasing an additional 133 shares in the last quarter. Alliance Wealth Advisors LLC UT raised its position in Cooper Companies by 3.8% during the 4th quarter. Alliance Wealth Advisors LLC UT now owns 11,262 shares of the medical device company’s stock valued at $1,035,000 after purchasing an additional 416 shares in the last quarter. Boston Trust Walden Corp raised its position in Cooper Companies by 10.0% during the 4th quarter. Boston Trust Walden Corp now owns 1,379,290 shares of the medical device company’s stock valued at $126,798,000 after purchasing an additional 125,475 shares in the last quarter. Jennison Associates LLC raised its position in Cooper Companies by 9.3% during the 4th quarter. Jennison Associates LLC now owns 885,598 shares of the medical device company’s stock valued at $81,413,000 after purchasing an additional 75,015 shares in the last quarter. Finally, Greenleaf Trust raised its position in Cooper Companies by 5.0% during the 4th quarter. Greenleaf Trust now owns 2,915 shares of the medical device company’s stock valued at $268,000 after purchasing an additional 139 shares in the last quarter. 24.39% of the stock is owned by institutional investors.

Cooper Companies Stock Up 0.1 %

Shares of COO stock opened at $93.63 on Tuesday. The Cooper Companies, Inc. has a 1-year low of $84.76 and a 1-year high of $112.38. The stock’s fifty day moving average price is $94.80 and its 200 day moving average price is $99.86. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The company has a market cap of $18.69 billion, a price-to-earnings ratio of 48.02, a price-to-earnings-growth ratio of 2.41 and a beta of 1.00.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, topping the consensus estimate of $1.00 by $0.04. The firm had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.03 billion. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm’s revenue for the quarter was up 9.8% on a year-over-year basis. During the same period in the previous year, the business earned $0.87 EPS. On average, research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on COO shares. Citigroup decreased their target price on Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research report on Friday, December 6th. Wells Fargo & Company boosted their price target on Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research report on Friday, December 6th. Morgan Stanley reduced their price target on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research report on Friday, December 6th. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Finally, StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Three equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $117.00.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.